Does jaundice of 16.8 need blue light treatment?

Jaundice refers to the bilirubin in the blood, which is divided into three types: total bilirubin, direct bilirubin and indirect bilirubin. The relationship is total bilirubin = direct bilirubin indirect bilirubin. Jaundice is total bilirubin. Total bilirubin of 16.8mg/dl is clinically called pathological jaundice, and blue light therapy can be considered at this time.

Under normal circumstances, the total serum bilirubin level of full-term infants does not exceed 12.9mg/dl, and the total serum bilirubin level of premature infants does not exceed 15mg/dl. Whether it is a newborn or a premature infant, a total serum bilirubin level of 16.8mg/dl exceeds the normal value and is pathological jaundice. At this time, intervention treatment can be considered, and blue light therapy can be accepted, which can promote the excretion of unconjugated bilirubin in the newborn's body. If not treated in time, the newborn may experience poor spirits, yellow skin, abnormal urine and stool color, and may even cause drowsiness and convulsions.

Under normal circumstances, the total serum bilirubin level of full-term infants does not exceed 12.9mg/dl, and the total serum bilirubin level of premature infants does not exceed 15mg/dl. Whether it is a newborn or a premature infant, a total serum bilirubin level of 16.8mg/dl exceeds the normal value and is pathological jaundice. At this time, intervention treatment can be considered, and blue light therapy can be accepted, which can promote the excretion of unconjugated bilirubin in the newborn's body. If not treated in time, the newborn may experience poor spirits, yellow skin, abnormal urine and stool color, and may even cause drowsiness and convulsions.

Parents must pay attention to the yellowing of the skin, sclera and other tissues of the newborn after birth. If there is any abnormality, they should take the child to the pediatric department of the hospital as soon as possible to complete relevant tests such as serum total bilirubin and transcutaneous bilirubin to determine whether the child suffers from pathological jaundice and needs treatment if necessary.